[go: up one dir, main page]

FI951596L - Menetelmä 10-desasetyylibakkatiini-III:n saamiseksi - Google Patents

Menetelmä 10-desasetyylibakkatiini-III:n saamiseksi Download PDF

Info

Publication number
FI951596L
FI951596L FI951596A FI951596A FI951596L FI 951596 L FI951596 L FI 951596L FI 951596 A FI951596 A FI 951596A FI 951596 A FI951596 A FI 951596A FI 951596 L FI951596 L FI 951596L
Authority
FI
Finland
Prior art keywords
deacetylbaccatin
iii
obtaining
Prior art date
Application number
FI951596A
Other languages
English (en)
Swedish (sv)
Other versions
FI109794B (fi
FI951596A0 (fi
Inventor
Jean-Claude Gaullier
Bernadette Mandard
Rodolphe Margraff
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI951596L publication Critical patent/FI951596L/fi
Publication of FI951596A0 publication Critical patent/FI951596A0/fi
Application granted granted Critical
Publication of FI109794B publication Critical patent/FI109794B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI951596A 1992-10-05 1995-04-04 Menetelmä 10-desasetyylibakkatiini-III:n saamiseksi FI109794B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9211746 1992-10-05
FR9211746A FR2696463B1 (fr) 1992-10-05 1992-10-05 Procédé d'obtention de la désacétyl-10 baccatine III.
PCT/FR1993/000972 WO1994007882A1 (fr) 1992-10-05 1993-10-04 Procede d'obtention de la desacetyl-10 baccatine iii
FR9300972 1993-10-04

Publications (3)

Publication Number Publication Date
FI951596L true FI951596L (fi) 1995-04-04
FI951596A0 FI951596A0 (fi) 1995-04-04
FI109794B FI109794B (fi) 2002-10-15

Family

ID=9434124

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951596A FI109794B (fi) 1992-10-05 1995-04-04 Menetelmä 10-desasetyylibakkatiini-III:n saamiseksi

Country Status (30)

Country Link
US (1) US5393895A (fi)
EP (1) EP0663910B1 (fi)
JP (1) JP3299754B2 (fi)
KR (1) KR100301236B1 (fi)
CN (1) CN1043530C (fi)
AT (1) ATE148883T1 (fi)
AU (1) AU680629B2 (fi)
CA (1) CA2146373C (fi)
CZ (2) CZ284615B6 (fi)
DE (1) DE69308155T2 (fi)
DK (1) DK0663910T3 (fi)
EE (1) EE03126B1 (fi)
ES (1) ES2098061T3 (fi)
FI (1) FI109794B (fi)
FR (1) FR2696463B1 (fi)
GE (1) GEP20001937B (fi)
GR (1) GR3022617T3 (fi)
HU (1) HU226862B1 (fi)
LT (1) LT3398B (fi)
LV (1) LV10621B (fi)
MX (1) MX9305771A (fi)
NO (1) NO310413B1 (fi)
NZ (1) NZ256450A (fi)
PL (1) PL177316B1 (fi)
RU (1) RU2107065C1 (fi)
SK (1) SK280949B6 (fi)
TW (1) TW255890B (fi)
UA (1) UA44227C2 (fi)
WO (1) WO1994007882A1 (fi)
ZA (1) ZA937313B (fi)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696462B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé d'obtention de la désacétyl-10 baccatine III.
ES2290074T3 (es) 1993-07-19 2008-02-16 Angiotech Pharmaceuticals, Inc. Composiciones anti-angiogenicas que contienen taxol y un vehiculo no biodegradable y su uso.
ATE188880T1 (de) * 1993-11-02 2000-02-15 Rhone Poulenc Rorer Gmbh Verfahren zum auftrennen eines gemisches
FR2714053B1 (fr) * 1993-12-22 1996-03-08 Pf Medicament Procédé d'extraction et d'isolement de la 10-désacétylbaccatine III.
CN1112433A (zh) * 1994-05-24 1995-11-29 郭明 红豆杉属植物提取物及其应用
CA2178541C (en) 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
FR2736355B1 (fr) * 1995-07-07 1997-11-07 Pf Medicament Procede d'extraction et d'isolement de la 10-desacetylbaccatine iii
US5750736A (en) * 1996-07-11 1998-05-12 Napro Biotherapeutics, Inc. Method for acylating 10-deacetylbaccatin III selectively at the c-10 position
US5965752A (en) * 1996-08-23 1999-10-12 Institut National De La Recherche Scientifique Preparative scale isolation and purification of taxanes
ES2195378T3 (es) 1997-08-21 2003-12-01 Univ Florida State Procedimiento para la sintesis de taxanos.
US6002024A (en) * 1998-07-27 1999-12-14 Dabur Research Foundation Process for the isolation of 14β-hydroxy-10-deacetyl baccatin-III
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
US6281368B1 (en) 2000-03-16 2001-08-28 Napro Biotherapeutics, Inc. Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III
US6495705B2 (en) 2000-03-16 2002-12-17 Napro Biotherapeutics, Inc. Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes
CA2307393A1 (en) 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
US20030157170A1 (en) * 2001-03-13 2003-08-21 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
CA2440935A1 (en) 2001-03-13 2002-09-19 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
EP1392254B1 (en) * 2001-04-20 2007-06-06 The University of British Columbia Micellar drug delivery systems for hydrophobic drugs
US7351542B2 (en) 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity
EP1594459B1 (en) 2002-12-30 2010-02-17 Angiotech International Ag Drug delivery from rapid gelling polymer composition
CA2525647A1 (en) 2003-05-16 2005-02-24 Intermune, Inc. Synthetic chemokine receptor ligands and methods of use thereof
US7407973B2 (en) 2003-10-24 2008-08-05 Intermune, Inc. Use of pirfenidone in therapeutic regimens
US7846940B2 (en) 2004-03-31 2010-12-07 Cordis Corporation Solution formulations of sirolimus and its analogs for CAD treatment
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US8003122B2 (en) 2004-03-31 2011-08-23 Cordis Corporation Device for local and/or regional delivery employing liquid formulations of therapeutic agents
KR20070045219A (ko) * 2004-07-02 2007-05-02 아이박스 파마슈티컬스 에스.알.오. 파클리탁셀과 세팔로마닌의 분리 방법
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
WO2006089218A2 (en) 2005-02-17 2006-08-24 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for modulating angiogenesis
WO2007062036A2 (en) 2005-11-21 2007-05-31 Med Institute, Inc. Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent
WO2007107305A2 (en) 2006-03-22 2007-09-27 Medigene Ag Treatment of triple receptor negative breast cancer
WO2008005284A2 (en) 2006-06-30 2008-01-10 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US8409601B2 (en) 2008-03-31 2013-04-02 Cordis Corporation Rapamycin coated expandable devices
US8420110B2 (en) 2008-03-31 2013-04-16 Cordis Corporation Drug coated expandable devices
US8273404B2 (en) 2008-05-19 2012-09-25 Cordis Corporation Extraction of solvents from drug containing polymer reservoirs
EP2859916B1 (en) 2008-05-22 2017-11-29 Galera Labs, LLC Combination of an antimitotic agent and a selective superoxide dismutase mimetic in antitumor therapy
WO2010005850A1 (en) 2008-07-08 2010-01-14 The J. David Gladstone Institutes Methods and compositions for modulating angiogenesis
US8642063B2 (en) 2008-08-22 2014-02-04 Cook Medical Technologies Llc Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
US20120303115A1 (en) 2011-05-25 2012-11-29 Dadino Ronald C Expandable devices coated with a rapamycin composition
US20120302954A1 (en) 2011-05-25 2012-11-29 Zhao Jonathon Z Expandable devices coated with a paclitaxel composition
EP2760848B1 (en) 2011-09-26 2018-11-28 Fresenius Kabi Oncology Limited Processes for the preparation of cabazitaxel involving c(7)-oh and c(13)-oh silylation or just c(7)-oh silylation
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
EP3539563A1 (en) 2012-07-19 2019-09-18 Redwood Bioscience, Inc. Antibody specific for cd22 and methods of use thereof
AU2013341711A1 (en) 2012-11-12 2015-05-21 Redwood Bioscience, Inc. Compounds and methods for producing a conjugate
CN103804326A (zh) * 2012-11-15 2014-05-21 刘胜远 一种从含10-去乙酰基巴卡亭ⅲ的浸膏分离和提纯10-去乙酰基巴卡亭ⅲ的方法
LT2956175T (lt) 2013-02-15 2017-12-11 The Regents Of The University Of California Chimerinis antigeno receptorius ir jo panaudojimo būdai
CN103145652B (zh) * 2013-03-05 2015-09-30 无锡尔云科技有限公司 一种从红豆杉属植物中提取紫杉醇及其衍生物的方法
CN105358531B (zh) 2013-03-14 2017-11-14 利兰-斯坦福大学初级学院的董事会 线粒体醛脱氢酶‑2调节剂和其使用方法
JP6745218B2 (ja) 2013-11-27 2020-08-26 レッドウッド バイオサイエンス， インコーポレイテッド ヒドラジニル−ピロロ化合物及び複合体を生成するための方法
WO2015127137A1 (en) 2014-02-19 2015-08-27 Aldea Pharmaceuticals, Inc. Mitochondrial aldehyde dehydrogenase 2 (aldh2) binding polycyclic amides and their use for the treatment of cancer
US10517961B2 (en) 2015-09-25 2019-12-31 ZY Therapeutics, Inc. Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
US10654875B2 (en) 2015-11-12 2020-05-19 The Board Of Trustees Of The Leland Stanford Junior University Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
TWI760319B (zh) 2015-12-30 2022-04-11 杏國新藥股份有限公司 乳癌治療
JP2019515677A (ja) 2016-04-26 2019-06-13 アール．ピー．シェーラー テクノロジーズ エルエルシー 抗体複合体ならびにそれを作製および使用する方法
UA123020C2 (uk) 2016-06-01 2021-02-03 Сервьє Айпі Юкей Лімітед Склади поліалкіленоксид-аспарагінази та способи їхнього виготовлення й використання
TWI852903B (zh) 2017-01-05 2024-08-21 杏國新藥股份有限公司 胰臟癌治療
SG11201906468TA (en) 2017-01-18 2019-08-27 F1 Oncology Inc Chimeric antigen receptors against axl or ror2 and methods of use thereof
EP3388082A1 (en) 2017-04-13 2018-10-17 Galera Labs, LLC Combination cancer immunotherapy with pentaaza macrocyclic ring complex
WO2018218004A1 (en) 2017-05-24 2018-11-29 The Board Of Regents Of The University Of Texas System Linkers for antibody drug conjugates
EA202091832A1 (ru) 2018-01-31 2021-01-11 ГАЛЕРА ЛЭБЗ, ЭлЭлСи Комбинированная терапия злокачественных новообразований макроциклическим кольцевым комплексом пентаазы и противоопухолевым агентом на основе платины
BR112020020930A2 (pt) 2018-04-11 2021-03-02 Ohio State Innovation Foundation composição de liberação de fármaco, método para tratar um distúrbio oftalmológico e kit
CN108904137A (zh) * 2018-05-27 2018-11-30 肖军威 一种卫生巾芯片的制备方法及卫生巾芯片的加工设备
US11897928B2 (en) 2018-07-18 2024-02-13 Manzanita Pharmaceuticals, Inc. Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
US11529402B2 (en) 2019-01-14 2022-12-20 Ignite Immunotherapy, Inc. Recombinant vaccinia virus and methods of use thereof
US11685904B2 (en) 2019-02-14 2023-06-27 Ignite Immunotherapy, Inc. Recombinant vaccinia virus and methods of use thereof
BR112021019701A2 (pt) 2019-04-02 2021-12-14 Kenjockety Biotechnology Inc Anticorpos multiespecíficos para antígeno de câncer de bomba de efluxo e composições, reagentes, kits e métodos relacionados aos mesmos
CN110317183B (zh) * 2019-08-08 2021-03-12 无锡紫杉药业有限公司 一种红豆杉天然提取产物的纯化方法
CA3163805A1 (en) 2019-12-12 2021-06-17 Ignite Immunotherapy, Inc. Variant oncolytic vaccinia virus and methods of use thereof
CA3164608A1 (en) 2020-01-29 2021-08-05 Kenjockety Biotechnology, Inc. Anti-mdr1 antibodies and uses thereof
US20230212305A1 (en) 2020-06-04 2023-07-06 Kenjockety Biotechnology, Inc. Anti-abcg2 antibodies and uses thereof
WO2021247423A1 (en) 2020-06-04 2021-12-09 Kenjockety Biotechnology, Inc. Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto
CA3189291A1 (en) 2020-07-14 2022-01-20 Pfizer Inc. Recombinant vaccinia virus
CN116490522A (zh) 2020-09-02 2023-07-25 肯乔克蒂生物技术股份有限公司 抗abcc1抗体及其应用
US20240010747A1 (en) 2020-11-13 2024-01-11 Kenjockety Biotechnology, Inc. Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
JP2023551203A (ja) 2020-11-20 2023-12-07 アール．ピー．シェーラー テクノロジーズ、エルエルシー 抗体－薬物コンジュゲートのためのグリコシド二重切断リンカー
CN112694458A (zh) * 2020-12-29 2021-04-23 重庆臻源红豆杉发展有限公司 一种10-去乙酰基巴卡亭ⅲ提取纯化方法
AU2022413942A1 (en) 2021-12-13 2024-05-30 William Robert Arathoon Living Trust Dated August 29, 2016 Anti-abcb1 antibodies
WO2023159220A1 (en) 2022-02-18 2023-08-24 Kenjockety Biotechnology, Inc. Anti-cd47 antibodies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629818B1 (fr) 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
FR2629819B1 (fr) 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
US5175315A (en) 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5136060A (en) 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
US5380916A (en) 1990-11-02 1995-01-10 University Of Florida Method for the isolation and purification of taxane derivatives
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
WO1992018492A1 (en) * 1991-04-19 1992-10-29 The University Of Mississippi Methods and compositions for isolating taxanes
IT1258838B (it) * 1992-01-31 1996-02-29 Indena Spa Processo per l'estrazione di tassolo e derivati da cultivar del genere taxus

Also Published As

Publication number Publication date
SK43395A3 (en) 1995-08-09
FI109794B (fi) 2002-10-15
GR3022617T3 (en) 1997-05-31
LTIP1397A (en) 1994-11-25
UA44227C2 (uk) 2002-02-15
HU226862B1 (en) 2009-12-28
CZ84595A3 (en) 1995-09-13
RU95110687A (ru) 1996-12-27
AU680629B2 (en) 1997-08-07
PL177316B1 (pl) 1999-10-29
DE69308155T2 (de) 1997-08-07
LV10621B (en) 1995-10-20
CN1043530C (zh) 1999-06-02
DK0663910T3 (da) 1997-03-10
JP3299754B2 (ja) 2002-07-08
ES2098061T3 (es) 1997-04-16
EP0663910A1 (fr) 1995-07-26
NO951282L (no) 1995-04-03
CA2146373A1 (fr) 1994-04-14
AU5115593A (en) 1994-04-26
LV10621A (lv) 1995-04-20
KR100301236B1 (ko) 2001-11-22
WO1994007882A1 (fr) 1994-04-14
PL308244A1 (en) 1995-07-24
KR950703550A (ko) 1995-09-20
JPH08501792A (ja) 1996-02-27
LT3398B (en) 1995-09-25
ZA937313B (en) 1994-04-25
GEP20001937B (en) 2000-02-05
ATE148883T1 (de) 1997-02-15
CN1085551A (zh) 1994-04-20
CA2146373C (fr) 2006-08-29
HU9500973D0 (en) 1995-06-28
EP0663910B1 (fr) 1997-02-12
RU2107065C1 (ru) 1998-03-20
CZ287065B6 (cs) 2000-08-16
NO310413B1 (no) 2001-07-02
TW255890B (fi) 1995-09-01
NZ256450A (en) 1996-11-26
SK280949B6 (sk) 2000-09-12
CZ284615B6 (cs) 1999-01-13
HUT72449A (en) 1996-04-29
FI951596A0 (fi) 1995-04-04
FR2696463B1 (fr) 1994-11-25
FR2696463A1 (fr) 1994-04-08
NO951282D0 (no) 1995-04-03
MX9305771A (es) 1994-05-31
EE03126B1 (et) 1998-10-15
US5393895A (en) 1995-02-28
DE69308155D1 (de) 1997-03-27

Similar Documents

Publication Publication Date Title
FI951596L (fi) Menetelmä 10-desasetyylibakkatiini-III:n saamiseksi
FI962069L (fi) Menetelmä karpolaktaamin valmistamiseksi
FI956135A0 (fi) Erotusmenetelmä
FI931736A0 (fi) Biodegraderbart tgf-b-leveranssystem foer benregeneration
FI950302L (fi) Menetelmä kreatiinivaraston lisäämiseksi
FI952422L (fi) Menetelmä finasteridin valmistamiseksi
NO921218L (no) Reseptor-rensemetode
FI925357L (fi) Rakennusmenetelmä
DE69302555D1 (de) Bremsverfahren
FI921621L (fi) Sprutmetod foer braensle
FI955800L (fi) Menetelmä aminoalkyyliganidiinien valmistamiseksi
FI931850L (fi) Menetelmä välituotteen valmistamiseksi
DE69128667D1 (de) Positionsbestimmungsmethode
FI964001L (fi) Menetelmä 7-trialkyylisilyylibakkatiini III:n valmistamiseksi
ITTO911046A1 (it) Metodo di sgrassaggio-pulitura
DK96392D0 (da) Modifikationsmetode
IT1270841B (it) Metodo per produrre formilimidazoli
DE69024139D1 (de) Fixiermethode
FI933816L (fi) Understaell foer raelsfordon
IT9020623A0 (it) procedimento
ID870B (id) Metode pembuatan ritsleting
BG93509A (bg) Метод за получаване на 2-хидрокси-3-фенокси- пропиламиносъединения
FI952134L (fi) Menetelmä alkyykibentseenin valmistamiseksi
FI910366L (fi) Menetelmä deoksimulundokandiinin valmistamiseksi
FI931051A (fi) Kuvausmenetelmä

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS PHARMA S.A.

MA Patent expired